Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1919 1
1957 1
1966 2
1970 1
1972 1
1973 4
1976 3
1977 2
1980 1
1981 1
1982 1
1983 2
1985 1
1986 3
1987 3
1988 3
1989 4
1990 5
1991 2
1992 9
1993 1
1994 5
1995 3
1996 7
1997 7
1998 5
1999 8
2000 4
2001 10
2002 12
2003 14
2004 10
2005 18
2006 14
2007 12
2008 14
2009 18
2010 22
2011 19
2012 15
2013 28
2014 24
2015 26
2016 23
2017 23
2018 23
2019 27
2020 46
2021 46
2022 27
2023 34
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

540 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.
Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, Himansu S, Schäfer A, Ziwawo CT, DiPiazza AT, Dinnon KH, Elbashir SM, Shaw CA, Woods A, Fritch EJ, Martinez DR, Bock KW, Minai M, Nagata BM, Hutchinson GB, Wu K, Henry C, Bahl K, Garcia-Dominguez D, Ma L, Renzi I, Kong WP, Schmidt SD, Wang L, Zhang Y, Phung E, Chang LA, Loomis RJ, Altaras NE, Narayanan E, Metkar M, Presnyak V, Liu C, Louder MK, Shi W, Leung K, Yang ES, West A, Gully KL, Stevens LJ, Wang N, Wrapp D, Doria-Rose NA, Stewart-Jones G, Bennett H, Alvarado GS, Nason MC, Ruckwardt TJ, McLellan JS, Denison MR, Chappell JD, Moore IN, Morabito KM, Mascola JR, Baric RS, Carfi A, Graham BS. Corbett KS, et al. Among authors: bock kw. Nature. 2020 Oct;586(7830):567-571. doi: 10.1038/s41586-020-2622-0. Epub 2020 Aug 5. Nature. 2020. PMID: 32756549 Free PMC article.
High-content CRISPR screening.
Bock C, Datlinger P, Chardon F, Coelho MA, Dong MB, Lawson KA, Lu T, Maroc L, Norman TM, Song B, Stanley G, Chen S, Garnett M, Li W, Moffat J, Qi LS, Shapiro RS, Shendure J, Weissman JS, Zhuang X. Bock C, et al. Nat Rev Methods Primers. 2022;2(1):9. doi: 10.1038/s43586-022-00098-7. Epub 2022 Feb 10. Nat Rev Methods Primers. 2022. PMID: 37214176 Free PMC article.
Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial Infarction.
Ruiz-Villalba A, Romero JP, Hernández SC, Vilas-Zornoza A, Fortelny N, Castro-Labrador L, San Martin-Uriz P, Lorenzo-Vivas E, García-Olloqui P, Palacio M, Gavira JJ, Bastarrika G, Janssens S, Wu M, Iglesias E, Abizanda G, de Morentin XM, Lasaga M, Planell N, Bock C, Alignani D, Medal G, Prudovsky I, Jin YR, Ryzhov S, Yin H, Pelacho B, Gomez-Cabrero D, Lindner V, Lara-Astiaso D, Prósper F. Ruiz-Villalba A, et al. Among authors: bock c. Circulation. 2020 Nov 10;142(19):1831-1847. doi: 10.1161/CIRCULATIONAHA.119.044557. Epub 2020 Sep 25. Circulation. 2020. PMID: 32972203 Free PMC article.
Dupilumab in persistent asthma with elevated eosinophil levels.
Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, Wang L, Kirkesseli S, Rocklin R, Bock B, Hamilton J, Ming JE, Radin A, Stahl N, Yancopoulos GD, Graham N, Pirozzi G. Wenzel S, et al. Among authors: bock b. N Engl J Med. 2013 Jun 27;368(26):2455-66. doi: 10.1056/NEJMoa1304048. Epub 2013 May 21. N Engl J Med. 2013. PMID: 23688323 Free article. Clinical Trial.
The primary end point was the occurrence of an asthma exacerbation; secondary end points included a range of measures of asthma control. ...
The primary end point was the occurrence of an asthma exacerbation; secondary end points included a range of measures of asthma contr …
Feasibility of yoga as a complementary therapy for patients with type 2 diabetes: The Healthy Active and in Control (HA1C) study.
Bock BC, Thind H, Fava JL, Dunsiger S, Guthrie KM, Stroud L, Gopalakrishnan G, Sillice M, Wu W. Bock BC, et al. Complement Ther Med. 2019 Feb;42:125-131. doi: 10.1016/j.ctim.2018.09.019. Epub 2018 Sep 26. Complement Ther Med. 2019. PMID: 30670230 Free PMC article. Clinical Trial.
MAIN OUTCOME MEASURES: Primary outcomes assessed feasibility and acceptability, including enrollment rates, attendance, study completion, and participant satisfaction. Secondary outcomes included HbA1c, physical activity, and measures of diabetes-related emotional distress …
MAIN OUTCOME MEASURES: Primary outcomes assessed feasibility and acceptability, including enrollment rates, attendance, study completion, an …
Selenocysteine.
Böck A, Thanbichler M. Böck A, et al. EcoSal Plus. 2004 Dec;1(1). doi: 10.1128/ecosalplus.3.6.1.1. EcoSal Plus. 2004. PMID: 26443372
The conversion of seryl-tRNASec into selenocysteyl-tRNASec is catalyzed by selenocysteine synthase, the product of the selA gene (previously the fdhA locus, which was later shown to harbor two genes, selA and selB). The crucial element for the regulation is a putative secondar …
The conversion of seryl-tRNASec into selenocysteyl-tRNASec is catalyzed by selenocysteine synthase, the product of the selA gene (previously …
Diagnosis and management of secondary causes of steatohepatitis.
Liebe R, Esposito I, Bock HH, Vom Dahl S, Stindt J, Baumann U, Luedde T, Keitel V. Liebe R, et al. Among authors: bock hh. J Hepatol. 2021 Jun;74(6):1455-1471. doi: 10.1016/j.jhep.2021.01.045. Epub 2021 Feb 10. J Hepatol. 2021. PMID: 33577920 Free article. Review.
In contrast to primary NAFLD, therapeutic interventions are available for many secondary causes of NAFLD. Accordingly, secondary causes of fatty liver disease should be considered during the diagnostic workup of patients with fatty liver disease, and treatment of th …
In contrast to primary NAFLD, therapeutic interventions are available for many secondary causes of NAFLD. Accordingly, secondary …
Corticosteroids and mania: A systematic review.
De Bock M, Sienaert P. De Bock M, et al. World J Biol Psychiatry. 2024 Mar;25(3):161-174. doi: 10.1080/15622975.2024.2312572. Epub 2024 Mar 13. World J Biol Psychiatry. 2024. PMID: 38363330 Review.
The primary outcome is the prevalence of (hypo)mania following corticosteroid administration. Secondary outcomes include potential risk factors, dose-response relationships, and differences among various corticosteroid formulations. ...
The primary outcome is the prevalence of (hypo)mania following corticosteroid administration. Secondary outcomes include potential ri …
Dissymmetric Triaryltriazines: Small Mass Columnar Glasses.
Nunes da Silva F, Marchi Luciano H, Stadtlober CH, Farias G, Durola F, Eccher J, Bechtold IH, Bock H, Gallardo H, Vieira AA. Nunes da Silva F, et al. Among authors: bock h. Chemistry. 2023 Aug 15;29(46):e202301319. doi: 10.1002/chem.202301319. Epub 2023 Jul 17. Chemistry. 2023. PMID: 37272583
Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.
Glechner A, Wagner G, Mitus JW, Teufer B, Klerings I, Böck N, Grillich L, Berzaczy D, Helbich TH, Gartlehner G. Glechner A, et al. Among authors: bock n. Cochrane Database Syst Rev. 2023 Mar 31;3(3):CD009632. doi: 10.1002/14651858.CD009632.pub3. Cochrane Database Syst Rev. 2023. PMID: 36999589 Free PMC article. Review.
Results from cohort studies with methodological limitations confirmed these findings. A secondary analysis of the J-START provided results from 19,213 women with dense and non-dense breasts. ...A meta-analysis of three cohort studies with data from 50,327 women with dense …
Results from cohort studies with methodological limitations confirmed these findings. A secondary analysis of the J-START provided re …
540 results